The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The “test‐of‐time” approach
Abstract
BACKGROUND: Some surgeons have advocated delaying resection of liver metastases to allow additional metastases which may be present, but are undetected, to be identified. This “test‐of‐time” approach can limit the number of resections performed on patients who ultimately will develop additional metastases. The current study evaluated the potential role and possible advantages of performing radiofrequency (RF) ablation during the interval between diagnosis and hepatic metastasectomy as part of a test‐of‐time management approach. METHODS: Eighty‐eight consecutive patients with 134 colorectal carcinoma liver metastases were potential candidates for hepatic metastasectomy. They were treated with percutaneous RF ablation using single (101 treatments) or triple‐probe cluster (22 treatments) 18‐gauge internally cooled electrodes. Treatment was performed under conscious sedation (22 of 119 treatments), anesthesia (14 of 119 treatments), or general anesthesia (83 of 119 treatments). At the time of the initial RF ablation procedure, 49 of 88 patients (56%) were found to have 1 metastasis, 32 of 88 patients (36%) had 2 metastases, and 7 of 88 patients (8%) had 3 metastases. Metastases ranged from 0.6 to 4.0 cm in greatest dimension (mean, 2.1 cm). Follow‐up with serial computed tomography scans scans ranged from 18 to 75 months (median, 33 months) after the initial RF ablation. RESULTS: A total of 119 RF ablations were performed. Complete necrosis was obtained in 53 of 88 patients (60%) and in 85 of 134 lesions (63%). During follow‐up of these 53 patients, 16 (30%) remained free of disease and 37 (70%) developed new lesions. New lesions were intrahepatic in 26 of 37 patients (70%), extrahepatic in 4 patients (11%), and both intrahepatic and extrahepatic in 7 patients (19%). Of 26 patients whose new lesions were intrahepatic only, 15 (58%) were retreated with RF and 7 were free of disease at the time of last follow‐up (median follow‐up, 28 months). Ten additional patients with only intrahepatic new lesions were deemed untreatable and 1 patient underwent resection. Overall, among the 53 patients in whom complete tumor necrosis was achieved after RF ablation therapy, 52 (98%) were spared surgical resection: 23 (44%) because they have remained free of disease and 29 (56%) because they developed disease progression. Among all 88 patients, 21 (24%) underwent resection after RF ablation (8 were free of disease at the time of last follow‐up), 23 (26%) remained free of disease after successful RF ablation, and 56 (64%) developed untreatable disease progression (44 after RF alone, 12 after RF and surgery). Lesions in 35 of 88 patients (40%) demonstrated local tumor recurrence on follow‐up imaging studies. Twenty of these 35 patients (57%) underwent surgical resection, whereas the remaining 15 patients (43%) developed additional, untreatable metastases. New lesions were intrahepatic in 9 of 15 patients (60%), extrahepatic in 1 of 15 patients (7%), and both intrahepatic and extrahepatic in 5 of 15 patients (33%). No patient who had been treated with RF ablation became unresectable due to the growth of metastases and there was no evidence of needle track seeding in any patient after RF ablation. Overall, among the 35 patients in whom complete tumor necrosis was not achieved after RF ablation therapy, 15 (43%) were spared surgical resection. CONCLUSIONS: The results of the current study suggest that current RF ablation techniques, when used as part of a test‐of‐time management approach, can decrease the number of resections performed. The approach results in complete tumor necrosis in some patients and provide an interval for others who ultimately will develop new intrahepatic and/or extrahepatic metastases to do so. Cancer 2003;97:3027–35. © 2003 American Cancer Society. DOI 10.1002/cncr.11426
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
Resection of colorectal liver metastases
Scheele, J., Stang, R., Altendorf‐Hofmann, A., & Paul, M. (1995) · World Journal of Surgery · doi:10.1007/bf00316981 · Cited by 1,539
Liver resection for colorectal metastases.
Fong, Y., Cohen, A. M., Fortner, J. G., Enker, W. E., Turnbull, A. D., Coit, D. G., Marrero, A. M., Prasad, M., Blumgart, L. H., & Brennan, M. F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.938 · Cited by 1,284
Small Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol Injection
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Solbiati, L., & Gazelle, G. S. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe40655 · Cited by 1,283
Self-citationCurley, S. A., Izzo, F., Delrio, P., Ellis, L. M., Granchi, J., Vallone, P., Fiore, F., Pignata, S., Daniele, B., & Cremona, F. (1999) · Annals of Surgery · doi:10.1097/00000658-199907000-00001 · Cited by 1,068
Hepatocellular Carcinoma: Radio-frequency Ablation of Medium and Large Lesions
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Ierace, T., Solbiati, L., & Gazelle, G. S. (2000) · Radiology · doi:10.1148/radiology.214.3.r00mr02761 · Cited by 1,013
Self-citationSolbiati, L., Livraghi, T., Goldberg, S. N., Ierace, T., Meloni, F., Dellanoce, M., Cova, L., Halpern, E. F., & Gazelle, G. S. (2001) · Radiology · doi:10.1148/radiol.2211001624 · Cited by 870
Self-citationHepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history
Scheele, J., Stangl, R., & Altendorf-Hofmann, A. (1990) · Journal of British Surgery · doi:10.1002/bjs.1800771115 · Cited by 836
Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.
Rossi, S., Di Stasi, M., Buscarini, E., Quaretti, P., Garbagnati, F., Squassante, L., Paties, C. T., Silverman, D. E., & Buscarini, L. (1996) · American Journal of Roentgenology · doi:10.2214/ajr.167.3.8751696 · Cited by 760
Factors influencing the natural history of colorectal liver metastases
Stangl, R., Altendorf-Hofmann, A., Charnley, R. M., & Scheele, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92529-1 · Cited by 722
Cited by
Mulier, S., Ni, Y., Jamart, J., Ruers, T., Marchal, G., & Michel, L. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000171032.99149.fe · Cited by 688
Park, I. J., Kim, H. C., Yu, C. S., Kim, P. N., Won, H. J., & Kim, J. C. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9625-z · Cited by 112
Lang, E. V., Berbaum, K. S., Pauker, S. G., Faintuch, S., Salazar, G. M., Lutgendorf, S., Laser, E., Logan, H., & Spiegel, D. (2008) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2008.01.027 · Cited by 107
Radiofrequency Ablation of Hepatic Metastases: Factors Influencing Local Tumor Progression
Liu, C.-H., Yu, C.-Y., Chang, W.-C., Dai, M.-S., Hsiao, C.-W., & Chou, Y.-C. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3738-y · Cited by 10
Metadata
- Authors
- Livraghi, T., Solbiati, L., Meloni, F., Ierace, T., Goldberg, S. N., & Gazelle, G. S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-05-29
- Volume
- 97
- Issue
- 12
- Pages
- 3027-3035
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2062209863
- Cited by
- 329
- References
- 32
- FWCI
- 15.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The “test‐of‐time” approach. https://app.cochat.ai/papers/10.1002/cncr.11426
- The paper
- Livraghi, T., Solbiati, L., Meloni, F., Ierace, T., Goldberg, S. N., & Gazelle, G. S. (2003). Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The “test‐of‐time” approach. Cancer. https://doi.org/10.1002/cncr.11426
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.